Wednesday | August 10, 2022 |
Market Status: OPEN

Market News


2022 Q1 report

Release Date: 5/16/2022 6:00:14 PM

IRIS Code: 0671E





Regarding the availability of the quarterly report at March 31st, 2022


Pursuant to the provisions of Law 24/2017, of Regulation no. 5/2018 of the Financial Supervisory Authority and of the financial calendar for 2022, ROPHARMA hereby notifies its shareholders and investors that the Financial Results at March 31st, 2022 will be available as of May 16, 2022, 18.00, as follows: online on the company website,, Investors Section, as well as in the link below.

Additional information can be requested on the phone 0268/547233 – Shareholding service or e-mail:




Dr. pharm. MIHAI MIRON



Information provided by IRIS, the news platform of the Bucharest Stock Exchange.


Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2016 Bucharest Stock Exchange. All rights reserved